KRAS and cancer: However, current models of oncogene addiction are notable for their limitations, as many KRAS mutant cell lines are not strictly dependent on continued KRAS expression, and KRAS mutant cancers have been classified into discrete molecular subtypes based on the degree of KRAS addiction13–15,18.